Effects of Potassium Salts on Blood Pressure and Target Organ Damage
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00160368|
Recruitment Status : Unknown
Verified April 2007 by St George's, University of London.
Recruitment status was: Recruiting
First Posted : September 12, 2005
Last Update Posted : April 25, 2007
|Condition or disease||Intervention/treatment||Phase|
|Hypertension||Behavioral: Potassium supplementation||Phase 3|
Randomised trials have shown that increasing potassium intake lowers blood pressure. However, most previous trials used potassium chloride. Whereas, potassium in fruits and vegetables is not a chloride salt, but a mixture of potassium phosphate, sulphate, citrate, and many organic anions, most of which are precursors of potassium bicarbonate. It is unclear whether non-chloride salt of potassium has greater or lesser effect on blood pressure compared to potassium chloride.
Experimental studies in animals and epidemiological studies in humans suggest that a high potassium intake may have beneficial effects on the cardiovascular system and the kidney, independent of its effect on blood pressure, and also reduce the risk of osteoporosis.
We propose to carry out a randomised double-blind trial to compare potassium bicarbonate with potassium chloride looking at their effect on blood pressure, and also to determine whether these potassium salts have beneficial effects on the cardiovascular system, kidney and bone health.
Comparisons: potassium chloride vs potassium bicarbonate vs placebo.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||45 participants|
|Intervention Model:||Crossover Assignment|
|Official Title:||Effect of Potassium Bicarbonate and Potassium Chloride on Blood Pressure and Markers of Target Organ Damage in Hypertensives|
|Study Start Date :||January 2005|
|Estimated Study Completion Date :||March 2008|
- Blood pressure and markers of target organ damage and bone health at 4 weeks of potassium supplementation.
- Comparisons among different treatments in blood pressure and markers of target organ damage and bone health.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00160368
|Contact: Feng J He, PhDemail@example.com|
|Contact: Graham A MacGregor, MDfirstname.lastname@example.org|
|St. George's University of London,||Recruiting|
|London, United Kingdom, SW17 0RE|
|Contact: Feng J He, PhD 0044-20-8725-5375 email@example.com|
|Contact: Graham A MacGregor, MD 0044-20-8725-5774 firstname.lastname@example.org|
|Principal Investigator: Feng J He, PhD|
|Principal Investigator: Graham A MacGregor, MD|
|Principal Investigator:||Graham A MacGregor, MD||St George's, University of London|